欧洲疾控中心-欧洲基于ECDC基因组的耐碳青霉烯鲍曼不动杆菌调查方案v1.3(英)

TECHNICAL REPORTSurvey protocol for the ECDC genomic-based survey of carbapenem-resistant Acinetobacter baumannii in EuropeVersion 1.3www.ecdc.europa.euECDC TECHNICAL REPORT Survey protocol for the ECDC genomic-based survey of carbapenem-resistant Acinetobacter baumannii in Europe Version 1.3 ii This protocol of the European Centre for Disease Prevention and Control (ECDC) was coordinated by the Antimicrobial Resistance and Healthcare-Associated Infections (ARHAI) Section and the Microbiology and Molecular Surveillance Group, Surveillance Section. This survey protocol is accompanied by the ‘Laboratory manual for the ECDC genomic-based survey Acinetobacter baumannii in Europe’ [1], which was developed in consultation with the ‘ECDC Expert Group for microbiological support to the ECDC CRAb survey’. The members of the Expert Group, and the recruitment process for group membership, are in Annex 1. Contributing authors Andreas Hoefer, Tommi Kärki, Pete Kinross, Daniel Palm, Dominique Monnet. Acknowledgements The consulted national experts for this protocol include the ECDC National Focal Points (NFPs) for Antimicrobial Resistance (AMR), the Operational Contact Points for Antimicrobial-resistant isolates (AMRISO), and the experts listed in Annex 1. These include the participants in virtual network meetings of the European Antimicrobial Resistance Genes Surveillance Network (EURGen-Net) in November 2023 and May 2024, and the ‘ECDC Expert Group for microbiological aspects of the CRAb survey’. Suggested citation: European Centre for Disease Prevention and Control. Survey protocol for the ECDC genomic-based survey of carbapenem-resistant Acinetobacter baumannii in Europe – Version 1.3. Stockholm: ECDC; 2024. Stockholm, July 2024 ISBN 978-92-9498-735-8 doi: 10.2900/226974 Catalogue number TQ-02-24-701-EN-N © European Centre for Disease Prevention and Control, 2024. Reproduction is authorised, provided the source is acknowledged. Cover photo courtesy of Frank Hansen and Pia Thurø Hansen, SSI, Denmark.TECHNICAL REPORT Survey protocol for the ECDC genomic-based survey of carbapenem-resistant Acinetobacter baumannii iii Contents Abbreviations ................................................................................................................................................ v Intended audience for this document ............................................................................................................... 1 Short overview of the survey .......................................................................................................................... 1 Background ................................................................................................................................................... 2 Relevant activities and legislation ............................................................................................................... 2 Epidemiology of carbapenem-resistant Acinetob

立即下载
综合
2024-07-22
52页
3.44M
收藏
分享

欧洲疾控中心-欧洲基于ECDC基因组的耐碳青霉烯鲍曼不动杆菌调查方案v1.3(英),点击即可下载。报告格式为PDF,大小3.44M,页数52页,欢迎下载。

本报告共52页,只提供前10页预览,清晰完整版报告请下载后查看,喜欢就下载吧!
立即下载
本报告共52页,只提供前10页预览,清晰完整版报告请下载后查看,喜欢就下载吧!
立即下载
水滴研报所有报告均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
相关图表
融资事件疾病领域分布
综合
2024-07-22
来源:2024年上半年中国创新药领域亮点概览
查看原文
融资事件药物类型领分布
综合
2024-07-22
来源:2024年上半年中国创新药领域亮点概览
查看原文
2024 上半年中国公司就创新药达成的 license-out 授权合作案例
综合
2024-07-22
来源:2024年上半年中国创新药领域亮点概览
查看原文
授权合作的药物类型分布
综合
2024-07-22
来源:2024年上半年中国创新药领域亮点概览
查看原文
上半年首次获批 IND 的 1 类新药-疾病领域分布
综合
2024-07-22
来源:2024年上半年中国创新药领域亮点概览
查看原文
首次获批 IND 的 1 类新药-药物类型分布
综合
2024-07-22
来源:2024年上半年中国创新药领域亮点概览
查看原文
回顶部
报告群
公众号
小程序
在线客服
收起